Neogen (NEOG) Change in Receivables (2010 - 2026)
Neogen's (NEOG) quarterly Change in Receivables came in at -$5.3 million in Q1 2026, down 39.38% year-on-year from -$8.7 million in Q1 2025, and down 183.91% quarter-over-quarter from $6.3 million in Q4 2025.
Neogen (NEOG) Change in Receivables (2010 - 2026) Analysis & Trends
Neogen's Change in Receivables history runs 17 years deep, the most recent figure standing at -$5.3 million for Q1 2026.
- On a quarterly basis, Change in Receivables fell 39.38% year-over-year to -$5.3 million in Q1 2026; TTM through Feb 2026 was -$19.1 million, a 272.7% decrease from a year earlier, with the FY2025 full-year figure at -$11.6 million, down 157.9% from the prior year.
- Change in Receivables eased to -$5.3 million in Q1 2026 per NEOG's latest filing, from $6.3 million in the prior quarter.
- Across five years, Change in Receivables topped out at $49.3 million in Q4 2022 and bottomed at -$17.6 million in Q3 2025.
- The 5-year median for Change in Receivables is -$536000.0 (2024), against an average of $3.1 million.
- Biggest YoY gain for Change in Receivables was 1267.72% in 2025; the steepest drop was 267.12% in 2025.
- Year by year, Change in Receivables stood at $49.3 million in 2022, then plunged by 74.41% to $12.6 million in 2023, then tumbled by 104.25% to -$536000.0 in 2024, then surged by 1267.72% to $6.3 million in 2025, then slumped by 183.91% to -$5.3 million in 2026.
- Per Business Quant, the three latest NEOG Change in Receivables figures stand at -$5.3 million (Q1 2026), $6.3 million (Q4 2025), and -$17.6 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 42.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -444.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 287.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 117.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 117.90 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | -124.60 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -141.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Neogen | 2.09 Bn | 1.93 Bn | 99.00 Mn | -5.25 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | -5.25 Mn |
| Feb 28, 2026 | -5.25 Mn |
| Nov 30, 2025 | 6.26 Mn |
| Nov 30, 2025 | 6.26 Mn |
| Aug 31, 2025 | -17.61 Mn |
| Aug 31, 2025 | -17.61 Mn |
| May 31, 2025 | -2.54 Mn |
| May 31, 2025 | -2.54 Mn |
| Feb 28, 2025 | -3.77 Mn |
| Feb 28, 2025 | -3.77 Mn |
| Nov 30, 2024 | -536,000.00 |
| Nov 30, 2024 | -536,000.00 |
| Aug 31, 2024 | -4.80 Mn |
| Aug 31, 2024 | -4.80 Mn |
| May 31, 2024 | 3.97 Mn |
| May 31, 2024 | 3.97 Mn |
| Feb 29, 2024 | 19.77 Mn |
| Feb 29, 2024 | 19.77 Mn |
| Nov 30, 2023 | 12.61 Mn |
| Nov 30, 2023 | 12.61 Mn |